Chargement en cours...
Post-translational modification of KRAS: potential targets for cancer therapy
Aberrant activation of the RAS superfamily is one of the critical factors in carcinogenesis. Among them, KRAS is the most frequently mutated one which has inspired extensive studies for developing approaches to intervention. Although the cognition toward KRAS remains far from complete, mounting evid...
Enregistré dans:
| Publié dans: | Acta Pharmacol Sin |
|---|---|
| Auteurs principaux: | , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Singapore
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8285426/ https://ncbi.nlm.nih.gov/pubmed/33087838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41401-020-00542-y |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|